ARAY PEER ANALYSIS

Accuray Incorporated — metric-by-metric comparison with peers and the industry median

ARAYAccuray Incorporated

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

ARAYIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ARAY	ANGEN	MEDTR	ONCSM	SN	4DX	Ind. Median
P/E	—	—	596.83	122.41	20.56●	—	27.44
P/B	0.76	1.32	1.08	13.36	2.48	-74.16●	2.48
EV/EBITDA	—	34.77	10.93	25.46	9.88●	—	15.23
P/S	0.07●	2.95	1.18	7.66	2.09	243.16	2.66

Financial Health
Metric	ARAY	ANGEN	MEDTR	ONCSM	SN	4DX	Ind. Median
Current Ratio	1.42	2.31	3.58	2.25	2.57	6.57●	3.28
Debt/Equity	437.3%	28.1%	1.0%	35.0%	62.9%	-22.6%●	44.7%
NetDebt/EBITDA	-22.14●	4.71	-1.64	0.42	1.72	0.71	0.82

Profitability
Metric	ARAY	ANGEN	MEDTR	ONCSM	SN	4DX	Ind. Median
Net Margin	-10.8%	-45.0%	0.2%	6.3%	10.1%●	-3,684.6%	-5.7%
ROE	-101.1%	-21.0%	0.2%	12.9%●	12.1%	—	-8.6%
ROA	-9.9%	-15.7%	0.2%	8.0%●	6.1%	-264.3%	-6.4%
EBITDA Margin	-1.5%	9.8%	9.4%	30.6%●	25.6%	-818.8%	5.2%

Growth + Dividend
Metric	ARAY	ANGEN	MEDTR	ONCSM	SN	4DX	Ind. Median
Rev. Growth	-7.9%	11.7%	6.5%	39.1%●	—	-26.0%	7.4%
NI Growth	—	—	-62.9%	—	—	—	16.7%
Div. Yield	—	0.0%	1.1%	0.0%	3.5%●	—	1.1%
Payout	—	0.0%	656.3%	0.0%	52.8%	—	39.0%

Valuation
Metric	ARAY	TELA	LUNG	OM	NNOX	MXCT	Ind. Median
P/E	—	—	—	—	—	—	27.44
P/B	0.76	-7.94●	1.27	0.78	0.69	0.77	2.48
EV/EBITDA	—	—	—	—	—	—	15.23
P/S	0.07●	0.51	0.66	0.74	6.01	4.02	2.66

Financial Health
Metric	ARAY	TELA	LUNG	OM	NNOX	MXCT	Ind. Median
Current Ratio	1.42	3.61	4.91	6.29	3.64	12.04●	3.28
Debt/Equity	437.3%	-1,084.3%●	123.0%	91.0%	6.0%	10.4%	44.7%
NetDebt/EBITDA	-22.14●	-0.52	0.11	0.96	0.74	-0.08	0.82

Profitability
Metric	ARAY	TELA	LUNG	OM	NNOX	MXCT	Ind. Median
Net Margin	-10.8%●	-49.3%	-60.1%	-63.7%	-523.8%	-121.2%	-5.7%
ROE	-101.1%	—	-86.2%	-53.2%	-50.1%	-21.3%●	-8.6%
ROA	-9.9%●	-54.2%	-39.3%	-27.2%	-44.4%	-18.4%	-6.4%
EBITDA Margin	-1.5%●	-40.2%	-54.5%	-48.6%	-336.6%	-107.3%	5.2%

Growth + Dividend
Metric	ARAY	TELA	LUNG	OM	NNOX	MXCT	Ind. Median
Rev. Growth	-7.9%	13.5%	1.2%	2.0%	25.7%●	-14.3%	7.4%
NI Growth	—	—	—	—	—	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ARAY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.